Clinical trial
Paroxetine Treatment in Outpatients With Comorbid PTSD and Substance Dependence
NCT00330239 · Medical University of South Carolina, Other · Completed
Key facts
| NCT number | NCT00330239 |
|---|---|
| Title | Paroxetine Treatment in Outpatients With Comorbid PTSD and Substance Dependence |
| Official title | Paroxetine Treatment in Outpatients With Comorbid PTSD and Substance Dependence |
| Lead sponsor | Medical University of South Carolina, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | PTSD |
| Intervention type | Drug |
| Interventions | Paroxetine CR |
| Enrollment | 25 |
| Start date | Jan 1, 2003 |
| Completion | May 1, 2005 |
| First posted | May 26, 2006 |
| Last update posted | Oct 3, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: